Company intelligence / Profile preview

Memento Medicines

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Memento Medicines is a private biotechnology company developing biologic therapies for retinal diseases. The company launched in 2026 as the fifth subsidiary financed by Sera Medicines, a biologics-focused accelerator formed in collaboration with RA Capital. Its lead and currently disclosed program is MMT-205, a bispecific antibody licensed from MabTics and Curacle that is designed to activate Tie2 and inhibit VEGF for retinal vascular diseases. Memento is advancing MMT-205 through IND-enabling studies with an initial focus on neovascular age-related macular degeneration and diabetic macular edema, and clinical studies are expected to begin in 2027. The company is backed by a syndicate of specialist healthcare investors and is structured to develop and commercialize licensed ophthalmology assets globally.

Therapeutic areas: Ophthalmology
Modalities: AntibodyBispecific monoclonal antibodyBiologic
Industry: Biotech

Partnerships

CuracleMabTicsSera Medicines

Beyond the preview

Go deeper on Memento Medicines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memento Medicines.

Explore the full profile